1. AB0440 CHANGES IN KEY LABORATORY VALUES WITH TOFACITINIB 5 MG BID TREATMENT IN PATIENTS WITH PSORIATIC ARTHRITIS AND RHEUMATOID ARTHRITIS. (June 2019) Authors: Rigby, William; Burmester, Gerd Rüdiger; Fitzgerald, Oliver; Azevedo, Valderilio F.; Nash, Peter; Graham, Daniela; Wang, Cunshan; Jones, Thomas Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 1682 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Addressing Challenges and Opportunities of "Less Well-Understood" Adaptive Designs. (January 2017) Authors: He, Weili; Gallo, Paul; Miller, Eva; Jemiai, Yannis; Maca, Jeff; Koury, Ken; Fan, Xiaoyin Frank; Jiang, Qi; Wang, Cunshan; Lin, Min Journal: Therapeutic innovation & regulatory science Issue: Volume 51:Number 1(2017:Jan.) Page Start: 60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Design and laser cladding of Ti–Fe–Zr alloy coatings. (June 2015) Authors: Wang, Cunshan; Dong, Chuang Journal: Materials today communications Issue: Volume 3(2015) Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. DIA's Adaptive Design Scientific Working Group (ADSWG): Best Practices Case Studies for "Less Well-understood" Adaptive Designs. (January 2017) Authors: Miller, Eva; Gallo, Paul; He, Weili; Kammerman, Lisa A.; Koury, Kenneth; Maca, Jeff; Jiang, Qi; Walton, Marc K.; Wang, Cunshan; Woo, Katherine; Fuller, Cynthia; Jemiai, Yannis Journal: Therapeutic innovation & regulatory science Issue: Volume 51:Number 1(2017:Jan.) Page Start: 77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effect of tofacitinib on pain, fatigue, health-related quality of life and work productivity in patients with active ankylosing spondylitis: results from a phase III, randomised, double-blind, placebo-controlled trial. Issue 2 (2nd June 2022) Authors: Navarro-Compán, Victoria; Wei, James Cheng-Chung; Van den Bosch, Filip; Magrey, Marina; Wang, Lisy; Fleishaker, Dona; Cappelleri, Joseph C; Wang, Cunshan; Wu, Joseph; Dina, Oluwaseyi; Fallon, Lara; Strand, Vibeke Journal: RMD open Issue: Volume 8:Issue 2(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy and Safety of Lersivirine Versus Etravirine for the Treatment of HIV-1 Infection in Patients with Prior Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Use and Evidence of NNRTI Resistance: A Randomized Phase 2B Trial. Issue 5 (September 2014) Authors: DeJesus, Edwin; Fätkenheuer, Gerd; Orrell, Catherine; Wang, Cunshan; Jones, James; Craig, Charles; Tawadrous, Margaret; Heera, Jayvant Journal: HIV clinical trials Issue: Volume 15:Issue 5(2014) Page Start: 209 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacy and safety of tofacitinib in Chinese patients with active psoriatic arthritis: a phase 3, randomised, double-blind, placebo-controlled study. Issue 1 (31st January 2023) Authors: Leng, Xiaomei; Lin, Wei; Liu, Shixue; Kanik, Keith; Wang, Cunshan; Wan, Weiguo; Jiang, Zhenyu; Liu, Yi; Liu, Shengyun; Zhang, Zhuoli; Zhang, Zhiyi; Xu, Jian; Tan, Wenfeng; Hu, Jiankang; Li, Jingyang; Liu, Ju; Gunay, Levent M.; Dina, Oluwaseyi; Kinch, Cassandra; Zeng, Xiaofeng Journal: RMD open Issue: Volume 9:Issue 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Fracture in clinical studies of tofacitinib in rheumatoid arthritis. (December 2022) Authors: Hansen, Karen E.; Mortezavi, Mahta; Nagy, Edward; Wang, Cunshan; Connell, Carol A.; Radi, Zaher; Litman, Heather J.; Adami, Giovanni; Rossini, Maurizio Journal: Therapeutic advances in musculoskeletal disease Issue: Volume 14(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. FRI0452 TOFACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS: ANALYSIS OF DERMATOLOGIC ENDPOINTS FROM 2 PHASE 3 STUDIES. (June 2019) Authors: Merola, Joseph F.; Papp, Kim; Nash, Peter; Gratacos-Masmitja, Jordi; Boehncke, Wolf-Henning; Thaçi, Diamant; Graham, Daniela; Hsu, Ming-Ann; Wang, Cunshan; Wu, Joseph; Young, Pamela Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 918 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme. Issue 4 (31st January 2023) Authors: Dougados, Maxime; Charles-Schoeman, Christina; Szekanecz, Zoltán; Giles, Jon T; Ytterberg, Steven R; Bhatt, Deepak L; Koch, Gary G; Vranic, Ivana; Wu, Joseph; Wang, Cunshan; Kwok, Kenneth; Menon, Sujatha; Connell, Carol A; Yndestad, Arne; Rivas, Jose L; Buch, Maya H Journal: Annals of the rheumatic diseases Issue: Volume 82:Issue 4(2023) Page Start: 575 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗